Cargando…

Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?

Detalles Bibliográficos
Autor principal: Spittau, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660743/
https://www.ncbi.nlm.nih.gov/pubmed/26692847
http://dx.doi.org/10.4103/1673-5374.165228
_version_ 1782402863838789632
author Spittau, Björn
author_facet Spittau, Björn
author_sort Spittau, Björn
collection PubMed
description
format Online
Article
Text
id pubmed-4660743
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-46607432015-12-11 Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease? Spittau, Björn Neural Regen Res Perspective Medknow Publications & Media Pvt Ltd 2015-10 /pmc/articles/PMC4660743/ /pubmed/26692847 http://dx.doi.org/10.4103/1673-5374.165228 Text en Copyright: © Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Perspective
Spittau, Björn
Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?
title Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?
title_full Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?
title_fullStr Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?
title_full_unstemmed Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?
title_short Transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?
title_sort transforming growth factor β1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in parkinson's disease?
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660743/
https://www.ncbi.nlm.nih.gov/pubmed/26692847
http://dx.doi.org/10.4103/1673-5374.165228
work_keys_str_mv AT spittaubjorn transforminggrowthfactorb1mediatedantiinflammationslowsprogressionofmidbraindopaminergicneurodegenerationinparkinsonsdisease